Urinary excretion of the pyridinium cross-links of collagen in systemic lupus erythematosus

Clinical Rheumatology

Volumn 17, Issue 4, 1998, Pages 271-276

  Kipen, Y ^a   Will, R ^c   Strauss, B J G ^a   Morand, E F ^b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Bone mineral density; Pyridinium crosslinks; Systemic lupus erythematosus

Indexed keywords

COLLAGEN; CREATININE; DEOXYPYRIDINOLINE; PYRIDINIUM DERIVATIVE; PYRIDINOLINE;

ADULT; ARTICLE; BONE DENSITY; BONE MINERAL; CONTROLLED STUDY; CROSS LINKING; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY EXCRETION;

ADOLESCENT; ADULT; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLLAGEN; COLLAGEN TYPE I; CREATININE; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; FEMALE; FEMUR NECK; HUMANS; LUMBAR VERTEBRAE; LUPUS ERYTHEMATOSUS, SYSTEMIC; MENOPAUSE; PEPTIDES;

EID: 0031712777     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01451004     Document Type: Article

References (43)

1. Kalla AA, Fataas AB, Jeqsop SJ, Bewerunge L. Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 1993;36:1726-34.
2. Formiga F, Moga I, Nolla JM, Pac M, Mitjavila F, Roig-Escofet D. Loss of bone mineral density in pre-menopausal women with systemic lupus erythematosus. Ann Rheum Dis 1995;54:274-6.
3. Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins lupus cohort: an update. Arthritis Care Res 1995;8:137-45.
4. Pons F, Peris P, Guanabens N, et al. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in premenopausal women. Br J Rheumatol 1995;34:742-6.
5. Houssiau FA, Lefebvre C, Depresseux G, Lambert M, Devogelaer JP, De Deuxchaisnes N. Trabecular and cortical bone loss in systemic lupus erythematosus. Br J Rheumatol 1996:35:244-7.
6. Sels F, Dequeker J, Verwilghen J, Mbuyi-Muamba J-M. Viewpoint SLE and osteoporosis: dependence and/or independence on glucocorticoids. Lupus 1996;5:89-92.
7. Kipen Y, Buchbinder R, Strauss BJG, Forbes A, Littlejohn GO, Morand EF. Prevalence of reduced bone mineral density in systemic lupus erythematosus and the role of glucocorticoids. J Rheumatol 1997;24:1922-9.
8. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. J Immunol 1991;147:117-23.
9. Al-Janadi M, Al-Balla S, Al-Dallan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993;13:58-67.
10. Tanaka Y, Watanabe K, Suzuki M, et al. Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus. J Clin Immunol 1989;9:415-20.
11. MacDonald BR. Gowen M. Cytokines and bone. Br J Rheumatol 1992;31:149-55.
12. Prummel MF, Wiersinga WM, Lips P, Sanders GTB, Sauerwein HP. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 1991;72:382-6.
13. Uebelhart D, Schlemmer A, Johansen J, Gineyts E, Christiansen C, Delmas PD. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 1991;72:367-3.
14. Seibel MJ, Cosman F, Shen V, et al. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in post-menopausal osteoporosis. J Bone Miner Res 1993;8:881-9.
15. Gladman D. Prognosis of systemic lupus erythematosus and the factors that affect it. Curr Opin Rheumatol 1991; 3:789-796.
16. Wallace DJ, Podell T, Weiner J, Klinenberg JR, Forouzesh S, Dubois EL. Systemic lupus erythematosus-survival patterns. JAMA 1981;245:934-8.
17. Lilley J, Walters BG, Heath DA, Drolc Z. In vivo and in vitro precision for bone density measured by dual-energy x-ray absorption. Osteoporosis Int 1991;1:141-6.
18. Cummings S, Black D. Bone mass measurements and risk of fracture in caucasian women: a review of findings from prospective studies. Am J Med 1995;98(suppl 2A):24S-8S.
19. Riis BJ. The role of bone loss. Am J Med 1995;98(suppl 2A):29S-32S.
20. Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res 1993;8(suppl 2):S549-S55.
21. McLaren AM, Hordon LD, Bird HA, Robins SP. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture. Ann Rheum Dis 1992;51:648-65.
22. Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 1991;6:639-44.
23. MacDonald AG, McHenry P, Robins SP, Reid DM. Relationship of urinary pyridinium crosslinks to disease extent and activity in osteoarthritis. Br J Rheumatol 1994;33:16-9.
24. Gough AKS, Peel NFA, Eastell R, Holder RL, Lilley J, Emery P. Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis. Ann Rheum Dis 1994;53:14-7.
25. Kollerup G, Hansen M, Horslev-Peterson. Urinary hydroxy-pyridinium cross-links of collagen in rheumatoid arthritis. Relation to disease activity and effects of methylprednisolone. Br J Rheumatol 1994;33:816-20.
26. Black D, Marabani M, Sturrock RD, Robins SP. Urinary excretion of the hydroxypyridium cross-links of collagen in patients with rheumatoid arthritis. Ann Rheum Dis 1989;48:641-4.
27. Hall GM, Spector TD, Delmas PD. Markers of bone metabolism in post-menopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy. Arthritis Rheum 1995;38:902-6.
28. Astbury C, Bird HA, McLaren AM, Robins SP. Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 1994;33:11-5.
29. Seibel MJ, Duncan A, Robins SP. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol 1989;16:964-70.
30. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
31. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
32. Black D, Duncan A, Robins SP. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem 1988;169:197-203.
33. Pratt DA, Daniloff Y, Duncan A, Robins SP. Automated analysis of the pyridinium crosslinks of collagen in tissue and urine using solid phase extraction and reversed-phase high-performance liquid chromatography. Anal Biochem 1992;207:168-75.
34. Cullum ID, Ell PJ, Ryder JP. X-ray dual-photon absorptiometry: a new method for the measurement of bone density. Br J Radiol 1989;62:587-92.
35. Payne RW (Chairman). Genstat 5 Release 3 Reference Manual 1993. Oxford: Clarendon Press.
36. Eastell R, Hampton L, Colwell A. Urinary collagen crosslinks are highly correlated with radio isotopic measurements of bone resorption. Proceedings of the third international symposium on osteoporosis, Aalborg, Denmark: Osteopress, 1990:51.
37. Gorai I, Taguchi Y, Chali O, Nakayama M, Minaguchi H. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover. Calcif Tiss Int 1997;60:317-22.
38. Keen RW, Nguyen T, Sobnack R, Perry LA, Thompson PW, Spector TD. Can biochemical markers predict bone loss at the hip and spine? A 4-year prospective study of 141 early postmenopausal women. Osteoporosis Int 1996;6:399-406.
39. Dresner-Pollack R, Parker RA, Poku M, Thompson J, Seibel MJ, Greenspan SL. Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tiss Int 1996;59:328-33.
40. Cosman F, Nieves J, Wilkinson D, Schnering D, Shen V, Lindsay R. Bone density change and biochemical indices of skeletal turnover. Calcif Tissue Int 1996;58:236-43.
41. Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res 1996;11:1531-8.
42. Reeve J, Pearson J, Mitchell A, et al. Evolution of spinal bone loss and biochemical markers of bone remodelling after menopause in normal women. Calcif Tissue Int 1995;57:105-10.
43. Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas P. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995;10:641-9.